Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.
Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.
Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells.
Viral evolution during structured treatment interruptions in chronically human immunodeficiency virus-infected individuals.
Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Viral dynamics during structured treatment interruptions of chronic human immunodeficiency virus type 1 infection.
Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.